The Human Element: Why Fully Autonomous AI in Healthcare Remains a Distant Horizon

The Grand Vision of Agentic AI in Healthcare

      The healthcare sector is abuzz with the transformative potential of agentic artificial intelligence (AI). These sophisticated systems are envisioned as capable of autonomous action, designed to plan, reason, and execute multi-step tasks with minimal human intervention. They promise to revolutionize patient care, from enhancing diagnostic accuracy and streamlining administrative burdens to delivering personalized medicine at scale. The market reflects this enthusiasm, with agentic AI startups attracting billions in investments and the global healthcare AI market projected to reach $5 billion by 2030. This surge is driven by the urgent need to address challenges like medical errors, a leading cause of death, positioning AI decision support tools as vital interventions for improved patient safety and operational efficiency.

      However, beneath the surface of this speculative optimism lies a more complex reality. Despite significant technical advancements and impressive performance on isolated benchmark tasks, the widespread clinical adoption of truly autonomous AI systems remains limited. This disconnect stems from practical hurdles related to safety, stringent regulatory requirements, and the profound implications for liability in high-stakes healthcare environments. The journey from controlled research settings to real-world clinical practice reveals an ongoing reliance on extensive human oversight, a stark contrast to the vision of fully independent AI agents.

Understanding the Structural Limits of Healthcare AI

      A comprehensive qualitative study, detailed in the research paper by Aránguiz Dias et al. (2026), delves into the practical constraints shaping agentic AI in healthcare. Based on interviews with a diverse group of stakeholders, including developers, implementers, and end-users like physicians, the research identifies three interconnected tensions that collectively limit the practical autonomy of AI in clinical settings. These tensions highlight the critical gap between technical aspirations, commercial incentives, and the non-negotiable demands of patient safety.

      These findings underscore that AI, while incredibly powerful as a tool, still functions primarily as an assistant, requiring human expertise to interpret, validate, and ultimately take responsibility for its outputs. Companies like ARSA Technology understand this nuanced reality, focusing on delivering AI solutions that augment human capabilities rather than seeking to replace them, ensuring robust oversight and practical integration.

Conceptual Fragmentation: What Exactly is "Agentic AI"?

      One of the primary tensions identified is a widespread "conceptual fragmentation" regarding the definition of ‘agentic AI.’ Across different disciplines and organizational roles, stakeholders lack a unified understanding of what constitutes an AI agent. For developers, it might imply advanced algorithms capable of self-correction and goal attainment. For clinicians, it could conjure images of an AI system making independent diagnostic or treatment decisions. Regulators, on the other hand, grapple with defining accountability when a system's "agency" is ill-defined.

      This ambiguity creates a significant challenge for governance. When the very definition of an "agent" is contested, it becomes difficult to establish clear accountability structures. Who is responsible when a system described as "agentic" makes an error? This lack of clarity allows different parties—developers, deployers, and even end-users—to implicitly or explicitly shift responsibility, obscuring the critical question of blame and liability when systems fail in safety-critical clinical environments.

The Autonomy Contradiction: Commercial Promises vs. Operational Realities

      Another significant tension is the "autonomy contradiction," where the commercial promises of agentic AI dramatically outpace its operational reality. Marketing discourse often portrays these systems as highly autonomous, capable of independent clinical reasoning and action. However, in practice, these systems typically operate under near-total human supervision. This strict oversight isn't merely a preference but a necessity, driven by paramount concerns over patient safety, complex regulatory frameworks, and the profound liability implications associated with medical outcomes.

      The gap between what is advertised and what is actually deployed leads to a credibility challenge. While AI tools can significantly enhance clinical workflows—for example, through advanced AI Video Analytics for monitoring patient safety or facility management—true autonomous decision-making in high-stakes medical contexts is far from achieved. The human-in-the-loop approach remains crucial, ensuring that AI acts as a sophisticated tool rather than an unguided agent, providing insights that human experts then act upon.

The Evaluation Blind Spot: Beyond Technical Benchmarks

      The third tension points to an "evaluation blind spot" in current assessment methodologies. Most prevailing benchmarks for healthcare AI heavily prioritize technical performance, such as diagnostic accuracy on specific datasets or success rates on medical licensing examinations like MedQA. While these metrics are valuable for technical development, they often fail to capture critical dimensions essential for safe and accountable real-world deployment.

      The research highlights that factors such as trust calibration between humans and AI, seamless integration into existing clinical workflows, and comprehensive risk management in safety-critical environments are often overlooked. This narrow focus can create a deceptive sense of readiness. A system may perform flawlessly in a lab setting but fall short when confronted with the complexities of human interaction, varied patient data, and dynamic clinical environments. Without evaluation frameworks that consider these sociotechnical aspects, the true impact of AI on patient outcomes, operational efficiency, and staff workload cannot be accurately assessed. This gap hinders the development of truly trustworthy and responsible AI systems in healthcare.

Building a Foundation for Responsible AI in Healthcare

      These three tensions—conceptual fragmentation, the autonomy contradiction, and the evaluation blind spot—are mutually reinforcing. An unclear definition of 'agentic' allows for exaggerated commercial claims, which persist partly because current evaluation methods do not measure the real-world factors that matter most for accountability. To advance meaningful accountability and ensure patient safety, a fundamental shift is required. This involves reconciling divergent framings of AI's role, developing evaluation practices that mirror institutional and operational realities, and critically examining how the 'agentic' label shapes expectations, liability, and the distribution of blame.

      Forward-thinking technology providers like ARSA Technology, experienced since 2018, champion an approach that focuses on production-ready AI tools designed for practical, real-world impact. Solutions such as ARSA's Self-Check Health Kiosk demonstrate how AI and IoT can automate routine tasks, reduce staff burden, and enhance patient data collection without requiring full AI autonomy. These systems empower healthcare professionals with actionable insights and efficient processes, maintaining the essential human oversight crucial for patient care. This ensures that AI serves as a powerful enhancer of human capabilities, delivering tangible ROI and reducing operational risks, rather than introducing new liabilities through unproven autonomy.

Conclusion

      The vision of fully autonomous agentic AI systems transforming healthcare is captivating, yet the current reality underscores the indispensable role of human oversight. The path forward for AI in healthcare involves clarity in definitions, realistic expectations, and robust evaluation frameworks that move beyond technical benchmarks to encompass sociotechnical safety and ethical implications. By acknowledging these structural limits, stakeholders can collaborate more effectively to develop and deploy AI solutions that truly enhance healthcare outcomes, bolster efficiency, and safeguard patient well-being, all while preserving accountability. The doctor will, and must, still see you now, augmented by intelligent tools rather than replaced by independent agents.

      To learn more about how ARSA Technology is building practical, high-impact AI and IoT solutions for various industries, we invite you to contact ARSA for a free consultation.

      Source: Aránguiz Dias, G., Jafari, K., Griffith, A., Aránguiz Dias, C., Kim, G. R., Saadeddin, L., & Kochenderfer, M. J. (2026). The Doctor Will (Still) See You Now: On the Structural Limits of Agentic AI in Healthcare. arXiv preprint arXiv:2602.18460.